Skip to main content
All lobbying filings

PUBLIC CITIZEN

PUBLIC CITIZEN filed a Q2 report for PUBLIC CITIZEN on July 21, 2025.

Lobbying for PUBLIC CITIZEN

All filings by PUBLIC CITIZEN · Everything PUBLIC CITIZEN has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 21, 2025.
 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$98,808
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 10
Banking

general banking issue, crypto legislation, Defense of CFPB, CRAs for overdraft, payments rule; stablecoin legislation.

Budget/Appropriations

FY 2025 appropriations, opposing policy riders in appropriations, budget reconciliations, opposition to budget resolution

Civil Rights/Civil Liberties

Introduction Call - Rep. McIver, Rep Lieu re. access to justice, civil justice, Sen. Hickenlooper re. Product Safety.

Consumer Issues/Safety/Products

H.R. 277, H.R. 357, H.R. H.R. 288, H.R. 890, H.R. 7528, H.R. 7533, H.R. 788, H.R. 3446, H.R. 115, H.R. 358, H.R. 7198, H.R. 7867, H.R. 8033, H.R. 9030, H.R. 9031, H.R. 9032, H.R. 9033, H.R. 9085. Regulatory reform, Stop Corporate Capture Act (H.R. 1507), Corner Post Reversal Act (H.R. 9014). Stop Corporate Capture Act (H.R. 1507, S. 4749), Comment Integrity and Management Act of 2024 (H.R. 7528). artificial intelligence safeguards, Blumenthal - product safety updates. REINS Act (H.R. 277). Green Tape Elimination Act.GOOD Act, Guidance Clarity Act, SOPRA, Stop Corporate Capture Act, Corner Post Reversal Act.

Taxation/Internal Revenue Code

Direct File, financial transaction tax.

Government Issues

Reauthorize Office of Congressional Ethics (OCE), Communications with Congressional staff about corporate lobbying disclosure, DC statehood, prohibiting congressional stock trading activity, Regulating Inaugural funding, Freedom of Information Act reform, ETHICS Act (HR 2678, S 1171), Inaugural Fund Integrity Act (HR 535), Campaign Finance Disclosure Legislation, Met with House Member staff to discuss. DISCLOSE Act. Presidential Conflict of Interest Act. Discussion about Campaign Finance Disclosure Policy Ideas. Communications with House staff re: potential campaign disclosure legislation, Drafting memo to House encouraging Campaign Disclosure legislation; Communications with House staff re: potential campaign disclosure legislation.

Health Issues

H.R.3421 & S.1655 - Medicare for All, Health care nominations, Medicare Advantage

Labor Issues/Antitrust/Workplace

heat stress, OSHA issues.

Pharmacy

anti-obesity medication pricing, Medicare drug price negotiation, international reference price negotiation price caps, number of drugs negotiated, out of pocket caps, inflation rebates, negotiation delay periods, direct-to-consumer pharmaceutical telehealth, Capping Prescription Costs Act, HHS Secretary, Deputy HHS Secretary, and CMS nominations, orphan drug exemption and negotiation delay period.H.R. 946 Orphan CURES Act; Medicare drug price negotiation eligibility delay period, S.652 Protecting Patients from Deceptive Drug Ads Online Act, EPIC Act (H.R. 1492 / S. 832), ORPHAN Cures Act (H.R.946), and MINI Act (H.R.1672); Medicare drug price negotiation delay periods and exemptions.

Postal

USPS issues

 Bills named in this filing 30
  • H.R. 277
    Limiting Section 230 Immunity to Good Samaritans Act
  • H.R. 357
    Back to Work Act
  • H.R. 288
    Long Island Sound Restoration and Stewardship Reauthorization Act of 2025
  • H.R. 890
    Stopping Pharma’s Ripoffs and Drug Savings For All Act
  • H.R. 7528
    Comment Integrity and Management Act of 2024
  • H.R. 7533
    RISE Reauthorization Act of 2026
  • H.R. 788
    DOE and SBA Research Act
  • H.R. 3446
    FDIC Board Accountability Act
  • H.R. 115
    No Free Rent for Freeloaders Act of 2025
  • H.R. 358
    No Corruption in Government Act
  • H.R. 7198
    Ensuring Access to General Surgery Act of 2026
  • H.R. 7867
    Infant Formula Safety Modernization Act of 2026
  • H.R. 8033
    Regulatory Transparency for Small Businesses Act
  • H.R. 9030
    Regulatory Agenda Clarity Act
  • H.R. 9031
    Young Adult Tax Credit Act
  • H.R. 9032
    Enhanced Regulatory Flexibility Assessment Act
  • H.R. 9033
    Timely Agreements Act
  • H.R. 9085
    Regulatory Review Improvement Act of 2024
  • H.R. 1507
    Stop Corporate Capture Act
  • H.R. 9014
    Corner Post Reversal Act
  • S. 4749
    Stop Corporate Capture Act
  • H.R. 2678
    Ending Trading and Holdings in Congressional Stocks (ETHICS) Act
  • H.R. 535
    Inaugural Fund Integrity Act
  • H.R. 3421
    Medicare for All Act
Show all 30 bills
  • S. 1655
    Medicare for All Act
  • S. 652
    Protecting Patients from Deceptive Drug Ads Act
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S. 832
    EPIC Act of 2025
  • H.R. 946
    ORPHAN Cures Act
  • H.R. 1672
    Maintaining Investments in New Innovation Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem